AstraZeneca vaccine doesn’t thwart South Africa variant in study data

AstraZeneca Plc’s embattled coronavirus vaccine didn’t offer much protection against mild disease caused by the variant that emerged in South Africa in a study that prompted the country to seek other immunizations last month. Source: BusinessTech